Enzychem Lifesciences Corporation (183490.KQ)

KRW 1329.0

(-2.71%)

Annual Balance Sheets

(In KRW)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 211.54 Billion 247.55 Billion 133.08 Billion 123.8 Billion 84.99 Billion 67.04 Billion
Total Current Assets 174.47 Billion 220.31 Billion 109.78 Billion 104.99 Billion 63.23 Billion 50.22 Billion
Cash And Short Term Investments 137.22 Billion 192.85 Billion 94.58 Billion 90.61 Billion 45.42 Billion 35.01 Billion
Cash and Cash Equivalents 15.47 Billion 7.68 Billion 2.78 Billion 1.85 Billion 2.28 Billion 3.6 Billion
Short Term Investments 121.75 Billion 185.17 Billion 91.8 Billion 88.75 Billion 43.13 Billion 31.41 Billion
Net Receivables 21.36 Billion 10.51 Billion 6.1 Billion 4.67 Billion 9.52 Billion 7.9 Billion
Inventory 14.94 Billion 9.79 Billion 8.35 Billion 9.17 Billion 7.84 Billion 7.12 Billion
Other Current Assets 940.89 Million 7.15 Billion 734.1 Million 531.67 Million 442 Million 171.43 Million
Total Non-Current Assets 37.07 Billion 27.24 Billion 23.3 Billion 18.8 Billion 21.75 Billion 16.82 Billion
Net PPE 26.16 Billion 23.29 Billion 15.43 Billion 15.66 Billion 14.81 Billion 14.06 Billion
Good Will And Intangible Assets 5.85 Billion 2.18 Billion 6.46 Billion 1.96 Billion 1.56 Billion 451.83 Million
Good Will 1.47 Billion - - - - -
Intangible Assets 4.37 Billion 2.18 Billion 6.46 Billion 1.96 Billion 1.56 Billion 451.83 Million
Long-Term Investments 2.03 Billion 529.47 Million 516.5 Million 538.68 Million 4.49 Billion 1.34 Billion
Tax Assets 571.39 Million -1.00 1.00 -1.00 -1.00 62.86 Million
Other Non Current Assets 2.44 Billion 1.23 Billion 884.09 Million 625.98 Million 887.31 Million 899.38 Million
Other Assets - 1.00 - 1.00 1.00 -
Total Liabilities 16.91 Billion 45.81 Billion 58.42 Billion 51.31 Billion 10.95 Billion 8.22 Billion
Total Current Liabilities 14.15 Billion 42.28 Billion 53.62 Billion 9.78 Billion 7.49 Billion 6.44 Billion
Account Payables 6.49 Billion 1.49 Billion 2.25 Billion 867.65 Million 2.73 Billion 987.05 Million
Tax Payables 172.58 Million - - - - -
Short Term Debt 4.04 Billion 36.58 Billion 48.62 Billion 5.62 Billion 2.79 Billion 3.57 Billion
Deferred Revenue 10.51 Million 130 Thousand 232.67 Million 127.08 Million 58.14 Million 26.1 Million
Other Current Liabilities 3.6 Billion 4.2 Billion 2.51 Billion 3.15 Billion 1.91 Billion 1.85 Billion
Total Non Current Liabilities 2.76 Billion 3.52 Billion 4.8 Billion 41.53 Billion 3.45 Billion 1.78 Billion
Long-Term Debt 1.02 Billion 683.32 Million 3.17 Billion 37.11 Billion 298.01 Million 300 Million
Deferred Revenue Non Current 584.45 Million - 179.97 Million 317.11 Million - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 440.22 Million 2.84 Billion 627.2 Million 1.4 Billion 3.15 Billion 1.48 Billion
Other Liabilities 1.00 1.00 - - 1.00 -
Total Equity 194.62 Billion 201.74 Billion 74.66 Billion 72.48 Billion 74.04 Billion 58.81 Billion
Stock Holders Equity 193.51 Billion 201.74 Billion 74.66 Billion 72.48 Billion 74.04 Billion 58.81 Billion
Common Stock 42.53 Billion 42.14 Billion 4.16 Billion 4.12 Billion 3.92 Billion 3.86 Billion
Retained Earnings 41.91 Billion -151.05 Billion -124.67 Billion -95.18 Billion -77.79 Billion -60.92 Billion
Accumulated other comprehensive income 16.34 Billion 16.28 Billion 16.52 Billion 14.99 Billion -628.11 Million 559.34 Million
Common Stock Equity 193.51 Billion 201.74 Billion 74.66 Billion 72.48 Billion 74.04 Billion 58.81 Billion
Capital Lease Obligation 584.45 Million 509.08 Million 179.97 Million 317.11 Million 298.01 Million -
Total Investments 123.79 Billion 185.7 Billion 92.31 Billion 89.29 Billion 47.62 Billion 32.76 Billion
Total Debt 5.65 Billion 37.77 Billion 51.97 Billion 43.06 Billion 3.08 Billion 3.87 Billion
Net Debt -9.81 Billion 30.09 Billion 49.19 Billion 41.2 Billion 801.77 Million 268.28 Million

Balance Sheet Charts